Investors in healthcare, hardware, climate tech and defence are feeling the impact of the Trump administration's policies.

The venture capital collective has recruited more than 80 credit unions for its second fintech-focused fund.

He will be joining the Mussallem Foundation to work on treatment for children with congenital heart disease.

US FDA and NIH cuts are expected to delay drug approvals and decrease grant funding, making it harder for young health sector companies to survive.

Power-hungry data centres are putting power grids under unprecedented strain, and National Grid Partners is racing to find new technologies that can keep networks running.

Cross border tariffs will raise materials costs and create investment uncertainty. Startups that can think globally and stay flexible will have the best chance of survival.

Tobias Egle has left his role working for the tech and biotech venture fund M Ventures after three years at the CVC.

Yamaryo was president and CEO of Itochu Corporation’s Tokyo-based CVC and subsidiary.

The federal cuts to science and research funding mean US universities are leaning more on spinout funds and tech transfer offices to generate income.

The investment includes a balance of developer control and investor returns and allows developers to own IP.